FBI LOGO.jpg
U.S. Biosimilars Market to Expand at 54.7% CAGR; Increasing Demand from the Unmet Populace to Create Growth Opportunities, says Fortune Business Insights
16 août 2019 09h00 HE | Fortune Business Insights
Pune, Aug. 16, 2019 (GLOBE NEWSWIRE) -- The U.S. Biosimilars Market will gain momentum from the increasing government support to adopt biosimilars in the healthcare sectors. According to a report by...